Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Active not recruiting 2 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 129 Breast Neoplasms 112 Neoplasms 93 Neoplasm Metastasis 79 Melanoma 71 Colorectal Neoplasms 70 Leukemia, Myeloid, Acute 67 Prostatic Neoplasms 59 Multiple Myeloma 52 Lung Neoplasms 52 Ovarian Neoplasms 49 Squamous Cell Carcinoma of Head and Neck 46 Triple Negative Breast Neoplasms 41 Recurrence 41 Carcinoma, Renal Cell 38 Carcinoma, Hepatocellular 38 Pancreatic Neoplasms 36 Myelodysplastic Syndromes 36 Glioblastoma 35 Brain Neoplasms 34 Stomach Neoplasms 30 Lymphoma, Non-Hodgkin 30 Lymphoma 30 Endometrial Neoplasms 30 Head and Neck Neoplasms 29 Lymphoma, Large B-Cell, Diffuse 27 Leukemia 27 Uterine Cervical Neoplasms 26 Cholangiocarcinoma 26 Urinary Bladder Neoplasms 24

Interventions

Tretinoin 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Breast Neoplasm Female × 1 year × Clear all

NCT04113863 2025-12-18

ATRA

Mario Negri Institute for Pharmacological Research

Phase 2 Terminated

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡